Phenylephrine Efficacy Will Be Questioned In Citizen Petition
This article was originally published in The Tan Sheet
A pharmacy professor intends to file a citizen petition asking FDA to re-examine the effectiveness of the nasal decongestant phenylephrine after the agency refused a similar request by Congress
You may also be interested in...
The patient self-assessed nasal congestion symptom score, not nasal air resistance, is the preferred tool to evaluate the effectiveness of an oral nasal decongestant such as phenylephrine, according to a report by a division of FDA's Office of New Drugs
A letter to the editor in the July Journal of Allergy & Clinical Immunology questioning phenylephrine efficacy inappropriately downplayed positive data in favor of negative studies, Wyeth Consumer Healthcare states in comments submitted to FDA Nov. 16
Schering-Plough released a study on phenylephrine's efficacy as compared to pseudoephedrine and placebo Oct. 31 that "raises even more questions" about the drug, according to Rep. Henry Waxman (D-Calif.)